Sun Pharma acquires 14 prescription brands from Novartis in Japan for $293 million
Sun Pharma will acquire the portfolio consisting of 14 established prescription brands from Novartis for a cash consideration of $293 million. These... Read More
CDSCO to start on surprise checks to drug manufacturing units in India
Posted on29 Mar 2016
Comments0
The Central Drugs Standard Control Organization is starting a series of surprise checks at various drug manufacturing units throughout the country next... Read More
Natco gets USFDA observation on 2 units
An inspection was conducted by the USFDA in two of its facilities recently — the Active Pharmaceutical Ingredients (API) manufacturing facility at... Read More
Zydus buys gastro therapy brand, Actibile from Albert David
Posted on28 Mar 2016
Comments0
Cadila Healthcare Limited has entered into a definitive agreement to acquire ‘Actibile’ from Albert David Limited (ADL). The brand falls in the... Read More
Merck partners With Harvard to Develop Cancer Treatments
Posted on28 Mar 2016
Tagsacute myeloid leukemia, AML, Matthew Shair, Merck, Merck partners With Harvard to Develop Cancer Treatments
Comments0
Harvard University will partner with Merck & Co. to develop small-molecule treatments for acute myeloid leukemia (AML) and other cancers, in a... Read More
Sigmoid Pharma to buy Irish arm of Japanese group Freund
Speciality drug business Sigmoid Pharma has agreed to buy the Irish business of Japanese pharmaceutical equipment group Freund. Dublin-based Sigmoid has developed... Read More
Cadila receives WHO finds faults in Moraiya vaccine plant in Gujarat
World Health Organization (WHO) cited violations of found “several major deviations” from standard procedures manufacturing and clinical standards. Cadila stopped production of... Read More
Sun Pharma partners with AstraZeneca India over Type II diabetes medicine dapagliflozin
Posted on24 Mar 2016
Comments0
Under the agreement, Sun Pharma will promote and distribute dapagliflozin under the brand name ‘Oxra’ Sun Pharma and AstraZeneca Pharma India announced... Read More
Fixed Dose Combination Ban: Now NPPA sent back 200 fixed dose combination applications
Posted on23 Mar 2016
Comments0
India’s drug price regulator National Pharmaceutical Pricing Authority (NPPA) has sent back 200 applications from various pharmaceutical companies, asking them to review... Read More
Novartis launches anti-psoriasis drug Scapho in India
Novartis Healthcare Pvt. Ltd (NHPL), a unit of Swiss multinational pharmaceutical company Novartis International AG on Thursday said it has launched a... Read More